April 25, 2024Twilightzonepinballmachine, Mei Nien Health (002044)Twilightzonepinballmachine.SZ) release the annual results report for 2023.
The company realized operating income of 10.894 billion yuan, an increase of 26.44% over the same period last year, and a net profit of 506 million yuan, turning losses into profits over the same period last year. The net cash flow generated by operating activities was 2.024 billion yuan, an increase of 30.34% over the same period last year, and the asset-liability ratio was 56.78%, up 0.86% from the same period last year.
The company's sales gross profit margin was 42.79%, up 8.35 percentage points from the same period last year, realizing basic earnings per share of 0.13 yuan, becoming a regular employee over the same period last year, and the rate of return on diluted net assets was 6.57%, a year-on-year increase.
The company's inventory turnover rate was 27.61 times, down 2.53 times from the same period last year, and the total asset turnover rate was 0.58 times, up 0.11 times from the same period last year.
The sales cost is about 2.563 billion yuan, the management cost is about 832 million yuan, and the financial cost is about 299 million yuan.
The company is mainly engaged in physical examination services and other services, with revenue of 10.561 billion yuan and 332 million yuan respectively.
The number of shareholders of the company is 120000, and the number of shares held by the top 10 shareholders is 1.509 billion shares, accounting for 38.56% of the total share capital. The top 10 shareholders are Alibaba (China) Network Technology Co., Ltd., Shanghai Tianyi Asset Management Co., Ltd., Hangzhou Xin Investment Information Technology Co., Ltd., Zhou Yuguang, Shanghai Qichun Investment Center (limited partnership), Shanghai Weitu Enterprise Development Center (limited partnership), Century Changhe Technology Group Co., Ltd., Hong Kong Securities Clearing Co., Ltd., Bank of China Co., Ltd.-Huabao China Medical Trading Index Securities Investment Fund, Shanghai Meixin Investment Management Co., Ltd. The shareholding ratio is 8.02%, 5.97%, 5.01%, 3.32%, 3.22%, 3.11%, 2.67%, 2.52%, 2.38% and 2.34%, respectively.
The company's total R & D expenditure is 98.25 million yuan, and R & D expenses account for 0.90% of business income, down 0.32% from the same period last year.
The above content has nothing to do with the data, has nothing to do with the position of the cloud channel in the interface, and does not constitute investment advice. Operate accordingly at your own risk.
